Search for: "Anda Inc."
Results 21 - 40
of 960
Sorted by Relevance
|
Sort by Date
30 Jan 2017, 9:16 pm
The case came to the Court from ANDA litigation between Eli Lilly and Teva and other ANDA filers over infringement under 35 U.S.C.... [read post]
2 May 2016, 6:17 am
The Federal Circuit held that Mylan Pharmaceuticals, Inc. [read post]
14 Apr 2015, 9:59 pm
Sandoz, Inc. [read post]
21 Aug 2022, 9:11 pm
Eagle Pharmaceuticals, Inc. [read post]
3 Sep 2020, 9:23 pm
The case arose in ANDA litigation over Amarin's... [read post]
14 Apr 2014, 9:59 pm
By Michael Greenfield -- Last Friday, the Federal Circuit issued an opinion in Hoffman La-Roche Inc. v. [read post]
21 Dec 2020, 9:03 pm
Maia Pharmaceuticals, Inc. [read post]
3 Dec 2014, 9:59 pm
TWI Pharmaceuticals, Inc., where the patentee prevailed only to face almost certain defeat on remand. [read post]
23 Dec 2021, 8:48 pm
Corcept Therapeutics, Inc. [read post]
14 Jul 2022, 9:55 pm
To recap, the case arose in ANDA... [read post]
12 Oct 2010, 9:59 pm
§ 2201) in the Hatch-Waxman context in Teva Pharmaceuticals USA, Inc. v. [read post]
14 Feb 2013, 9:59 pm
Indeed, the current squabble over "reverse payment" settlement agreements of lawsuits under the ANDA provisions of the Hatch-Waxman Act (codified at 35 U.S.C. [read post]
2 Sep 2016, 2:15 am
In Acorda Therapeutics, Inc. v. [read post]
20 Apr 2010, 9:34 am
., Inc. v. [read post]
15 May 2012, 1:00 am
Sunovion Pharmaceuticals, Inc., the Federal Circuit affirmed the district court’s determination that it could exercise jurisdiction over a declaratory judgment action brought by a subsequent ANDA filer. [read post]
13 Sep 2017, 7:44 am
Mylan Pharmaceuticals, Inc., 1-17-cv-00379 (DED September 11, 2017, Order) (Stark, USDJ) [read post]
14 May 2015, 9:59 pm
Earlier this week, the Federal Circuit continued this expansion in Classen Immunotherapies, Inc. v. [read post]
5 Dec 2017, 7:21 am
Actavis Laboratories UT, Inc. et al, 3-17-cv-01076 (TXND November 17, 2017, Order) (Lynn, USDJ) [read post]
14 Jan 2013, 10:05 am
Judge Sue Robinson has issued an order enjoining ANDA defendant Tolmar, Inc. from launching its generic product at the expiration of the 30-month stay. [read post]
19 Aug 2022, 6:59 am
., Inc. v. [read post]
